Testosterone cyclopentylpropionate: Clinical Trials

2 trials of Testosterone cyclopentylpropionate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1

Follow Testosterone cyclopentylpropionate: new trials by email Literature Review of Testosterone cyclopentylpropionate trials Research Report on Testosterone cyclopentylpropionate

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Exposure to Substances Prohibited by the World Anti-Doping Agency in Healthy Volunteers.
Bupropion, Anastrozole, Testosterone cyclopentylpropionate - Healthy Volunteers
Phase 1CompletedParc de Salut Mar92020-12-032021-04-26
Testosterone and Olaparib in Treating Patients With Castration-Resistant Prostate Cancer
Laboratory Biomarker Analysis, Olaparib, Quality-of-Life Assessment - Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma
Phase 2CompletedUniversity of Washington362018-08-292025-09-29

Sponsors

Parc de Salut Mar (1)  ·  University of Washington (1)

Countries

Spain (1)  ·  United States (1)

Top investigators

Ana M Aldea Perona, MD PhD (1)  ·  Michael T. Schweizer (1)

NIH funding

P30CA015704 (1)